J
Judith A. Ferry
Researcher at Harvard University
Publications - 220
Citations - 16766
Judith A. Ferry is an academic researcher from Harvard University. The author has contributed to research in topics: Lymphoma & Follicular lymphoma. The author has an hindex of 64, co-authored 210 publications receiving 14567 citations. Previous affiliations of Judith A. Ferry include Indiana University – Purdue University Indianapolis & Massachusetts Eye and Ear Infirmary.
Papers
More filters
Journal ArticleDOI
Consensus statement on the pathology of IgG4-related disease
Vikram Deshpande,Yoh Zen,John Kc Chan,Eunhee E Yi,Yasuharu Sato,Tadashi Yoshino,Günter Klöppel,J. Godfrey Heathcote,Arezou Khosroshahi,Judith A. Ferry,Rob C. Aalberse,Daniel Bloch,William R. Brugge,Adrian C Bateman,Mollie N. Carruthers,Suresh T. Chari,Wah Cheuk,Lynn D. Cornell,Carlos Fernandez-del Castillo,David G. Forcione,Daniel L. Hamilos,Terumi Kamisawa,Satomi Kasashima,Shigeyuki Kawa,Mitsuhiro Kawano,Gregory Y. Lauwers,Yasufumi Masaki,Yasuni Nakanuma,Kenji Notohara,Kazuichi Okazaki,Ji Kon Ryu,Takako Saeki,Dushyant V. Sahani,Thomas C. Smyrk,James Robert Stone,Masayuki Takahira,George Webster,Motohisa Yamamoto,Giuseppe Zamboni,Hisanori Umehara,John H. Stone +40 more
TL;DR: This statement proposes a terminology scheme for the diagnosis of IgG4-related disease that is based primarily on the morphological appearance on biopsy, and advocates the use of strict criteria for accepting newly proposed entities or sites as components of the IgG 4- related disease spectrum.
Journal ArticleDOI
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Dennis M. Willerford,Jianzhu Chen,Judith A. Ferry,Laurie Davidson,Averil Ma,Averil Ma,Frederick W. Alt,Frederick W. Alt +7 more
TL;DR: Interleukin-2 receptor alpha chain expression occurs at specific stages of early T and B lymphocyte development and is induced upon activation of mature lymphocytes, probably by influencing the balance between clonal expansion and cell death following lymphocyte activation.
Journal ArticleDOI
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury,Eric Solary,Oussama Abla,Yassmine Akkari,Rita Alaggio,Jane F. Apperley,Rafael Bejar,Emilio Berti,Lambert Busque,John K.C. Chan,Weina Chen,Xi Chen,Wee Joo Chng,John K. Choi,Isabel Colmenero,Sarah E. Coupland,Nicholas C.P. Cross,Daphne de Jong,M. Tarek Elghetany,Emiko Takahashi,Jean-François Emile,Judith A. Ferry,Linda Fogelstrand,Michaela Fontenay,Ulrich Germing,Sumeet Gujral,Torsten Haferlach,Claire N. Harrison,Jennelle C. Hodge,Shimin Hu,Joop H. Jansen,Rashmi Kanagal-Shamanna,Hagop M. Kantarjian,Christian P. Kratz,Xiao-Qiu Li,Megan S. Lim,Keith R. Loeb,Sanam Loghavi,Andrea N. Marcogliese,Soheil Meshinchi,Phillip Michaels,Kikkeri N. Naresh,Yasodha Natkunam,Reza Nejati,German Ott,Eric Padron,Keyur Patel,Nikhil Patkar,Jennifer Picarsic,Uwe Platzbecker,Irene Roberts,Anna Schuh,William C. Sewell,Reiner Siebert,Prashant Tembhare,Jeffrey W. Tyner,Srdan Verstovsek,Wei Wang,Brent L. Wood,W Q Xiao,Cecilia Yeung,Andreas Hochhaus +61 more
TL;DR: The 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database as discussed by the authors .
Journal ArticleDOI
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations
John H. Stone,Arezou Khosroshahi,Vikram Deshpande,John K.C. Chan,J. Godfrey Heathcote,Rob C. Aalberse,Atsushi Azumi,Daniel Bloch,William R. Brugge,Mollie N. Carruthers,Wah Cheuk,Lynn D. Cornell,Carlos Fernandez-del Castillo,Judith A. Ferry,David G. Forcione,Günter Klöppel,Daniel L. Hamilos,Terumi Kamisawa,Satomi Kasashima,Shigeyuki Kawa,Mitsuhiro Kawano,Yasufumi Masaki,Kenji Notohara,Kazuichi Okazaki,Ji Kon Ryu,Takako Saeki,Dushyant V. Sahani,Yasuharu Sato,Thomas C. Smyrk,James R. Stone,Masayuki Takahira,Hisanori Umehara,George Webster,Motohisa Yamamoto,Eunhee S. Yi,Tadashi Yoshino,Giuseppe Zamboni,Yoh Zen,Suresh T. Chari +38 more
TL;DR: John H. Stone, Arezou Khosroshahi, Vikram Deshpande, John K.Stone, Masayuki Takahira, Hisanori Umehara, George Webster, Motohisa Yamamoto, Eunhee Yi, Tadashi Yoshino, Giuseppe Zamboni, Yoh Zen, and Suresh Chari.
Journal ArticleDOI
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy,Margaretha G.M. Roemer,Margaretha G.M. Roemer,Chip Stewart,Yuxiang Tan,Ryan Abo,Liye Zhang,Andrew Dunford,David Meredith,Aaron R. Thorner,Ekaterina S. Jordanova,Gang Liu,Friedrich Feuerhake,Matthew D. Ducar,Gerald Illerhaus,Daniel Gusenleitner,Erica Linden,Heather Sun,Heather Homer,Miyuki Aono,Geraldine S. Pinkus,Azra H. Ligon,Keith L. Ligon,Judith A. Ferry,Gordon J. Freeman,Paul Van Hummelen,Todd R. Golub,Todd R. Golub,Gad Getz,Gad Getz,Scott J. Rodig,Daphne de Jong,Stefano Monti,Margaret A. Shipp +33 more
TL;DR: These studies identify unique combinations of genetic alterations in discrete LBCL subtypes and subtype-selective bases for targeted therapy and characterize their recurrent somatic mutations, chromosomal rearrangements, copy number alterations (CNAs), and associated driver genes.